N/A
Completed N=7
Vagal Nerve Stimulation and Glucose Metabolism
Type 2 Diabetes · Obesity · Gastric Emptying
Source: ClinicalTrials.gov NCT01117311 ↗
Enrolled (actual)
7
Serious AEs
0.0%
Results posted
Jan 2014
Primary outcomePrimary: Disposition Index — 703; 532 10^-14dl/kg/min^2 per pmol/l
Summary
The overall aim of this application is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism. The study proposed will examine the effect of vagal nerve stimulation on insulin secretion and action.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Disposition Index |
703; 532 | — |
| SECONDARY Gastric Emptying Half-time |
167; 160 | — |
Eligibility Criteria
Previous Implantation of a Vagal Nerve Stimulator for obesity as part of a prior study examining the effect of vagal nerve stimulator on obesity
Data sourced from ClinicalTrials.gov (NCT01117311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.